April numbers should be available shortly. Some information about sales outside of the US would be good.Lifx:Mar 2019: $1.9mFeb 2019: $2.9mJanuary 2019: $3.4M
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%